(˗)epigallocatechin - Compound Card

(˗)epigallocatechin

Select a section from the left sidebar

(˗)epigallocatechin

Structure
Zoomed Structure
  • Family: Plantae - Cistaceae
  • Kingdom: Plantae
  • Class: Flavonoid
Canonical Smiles Oc1cc2O[C@H](c3cc(O)c(c(c3)O)O)[C@@H](Cc2c(c1)O)
InChI InChI=1S/C15H13O6/c16-8-5-10(17)9-1-2-13(21-14(9)6-8)7-3-11(18)15(20)12(19)4-7/h2-6,13,16-20H,1H2/t13-/m0/s1
InChIKey STTCSONHDOMVJH-ZDUSSCGKSA-N
Formula C15H13O6
HBA 6
HBD 5
MW 289.26
Rotatable Bonds 1
TPSA 110.38
LogP 2.1
Number Rings 3
Number Aromatic Rings 2
Heavy Atom Count 21
Formal Charge 0
Fraction CSP3 0.13
Exact Mass 289.07
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Helianthemum sessiliflorum Cistaceae Plantae 2650562

Showing of synonyms

  • Benabdelaziz I, Haba H, et al. (2015). Lignans and other constituents from Helianthemum sessiliflorum Pers.. Records of Natural Products,2015,9(3),342-348. [View]
Pubchem: 72277
Kegg Ligand: C12136
Chebi: 42255
Nmrshiftdb2: 60021305
Metabolights: MTBLC42255
Drugbank: DB03823
Pdb Ligand: EGT
Bindingdb: 50187665
CPRiL: 3433
Structure

SMILES: c1cccc(c12)OC(CC2)c3ccccc3

Level: 1

Mol. Weight: 289.26 g/mol

Structure

SMILES: C1CCOc(c12)cccc2

Level: 0

Mol. Weight: 289.26 g/mol

Structure

SMILES: c1ccccc1

Level: 0

Mol. Weight: 289.26 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.96
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.120
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.17

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.620
Plasma Protein Binding
82.31
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
15.220
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.160
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Toxic
Maximum Tolerated Dose
0.630
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.490
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Toxic
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
2.950
Rat (Acute)
2.070
Rat (Chronic Oral)
2.540
Fathead Minnow
4.070
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
462.980
Hydration Free Energy
-12.850
Log(D) at pH=7.4
1.270
Log(P)
0.47
Log S
-2.06
Log(Vapor Pressure)
-8.96
Melting Point
238.81
pKa Acid
7.5
pKa Basic
8.16

No predicted protein targets found for this compound.

Download SDF